Atlas Trials

Human Embryonic Stem Cell-Derived Cardiomyocyte Therapy for Chronic Ischemic Left Ventricular Dysfunction

Clinical trial NCT05068674 · RECRUITING

Trial details

NCT number
NCT05068674
Sponsor
Joseph C. Wu
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Chronic Ischemic Left Ventricular Dysfunction
Start date
2022-03-22
Primary completion
2028-10-01
Enrollment
18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.